International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 4 , Pages 1143-1150 , 15 July 2008

Intensity-Modulated Radiotherapy for Resected Mesothelioma: The Duke Experience

Received 8 October 2007 ,Revised 8 November 2007 ,Accepted 9 November 2007.

References 

  1. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591–1603
  2. Baldini EH, Recht A, Strauss GM, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997;63:334–338
  3. Pass HI, Kranda K, Temeck BK, et al. Surgically debulked malignant pleural mesothelioma: Results and prognostic factors. Ann Surg Oncol. 1997;4:215–222
  4. Ahamad A, Stevens CW, Smythe WR, et al. Intensity-modulated radiation therapy: A novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2003;55:768–775
  5. Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65:640–645
  6. Forster KM, Smythe WR, Starkschall G, et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: Clinical implementation. Int J Radiat Oncol Biol Phys. 2003;55:606–616
  7. Ismail-Khan R, Robinson LA, Williams CC, et al. Malignant pleural mesothelioma: A comprehensive review. Cancer Control. 2006;13:255–263
  8. Stahel RA. Malignant pleural mesothelioma: A new standard of care. Lung Cancer. 2006;54(Suppl. 2):S9–S14
  9. van Ruth S, Baas P, Zoetmulder FA. Surgical treatment of malignant pleural mesothelioma: A review. Chest. 2003;123:551–561
  10. Zellos LS, Sugarbaker DJ. Multimodality treatment of diffuse malignant pleural mesothelioma. Semin Oncol. 2002;29:41–50
  11. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636–2644
  12. Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2001;122:788–795
  13. Treasure T, Tan C, Lang-Lazdunski L, et al. The MARS trial: Mesothelioma and radical surgery. Interact Cardiovasc Thorac Surg. 2006;5:58–59
  14. Chan P, Yeo I, Perkins G, et al. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: A retrospective planning study. Radiat Oncol. 2006;1:13
  15. Christian JA, Bedford JL, Webb S, et al. Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non–small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67:735–741
  16. Cozzi L, Fogliata A, Bolsi A, et al. Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: Comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys. 2004;58:617–624
  17. Harsolia A, Kestin L, Grills I, et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:1375–1380
  18. Milano MT, Jani AB, Farrey KJ, et al. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2005;63:354–361
  19. Zelefsky MJ, Chan H, Hunt M, et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol. 2006;176:1415–1419
  20. Gregory DL, Fairfoul J, Chantler H, et al. Intensity modulated radiotherapy to deliver hemithorax irradiation for mesothelioma for the MARS trial. Clin Oncol (R Coll Radiol). 2007;19:S30
  21. Rice DC, Smythe WR, Liao Z, et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2007;69:350–357
  22. Brunelli A, Sabbatini A, Xiume F, et al. A model to predict the decline of the forced expiratory volume in one second and the carbon monoxide lung diffusion capacity early after major lung resection. Interact Cardiovasc Thorac Surg. 2005;4:61–65

 Presented at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Los Angeles, CA, October 28–November 1, 2007.

 Conflict of interest: Duke receives research support from Varian Medical Systems.

PII: S0360-3016(07)04571-3

doi: 10.1016/j.ijrobp.2007.11.011

International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 4 , Pages 1143-1150 , 15 July 2008

Article Tools

* Image Usage & Resolution